Skip to main content
SleepCited

[Melatonin for the regulation of sleep and other biological rhythms].

I V Zhdanova, M G Poluectov
Review Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2024
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'pmid\u003D38934660'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

Studientyp
Review
Population
Patients with insomnia or circadian disorders
Intervention
[Melatonin for the regulation of sleep and other biological rhythms]. Melatonin (low dose, 0.5-2 mg)
Vergleichsgruppe
None
Primärer Endpunkt
Sleep and circadian rhythm regulation
Wirkungsrichtung
Positive
Verzerrungsrisiko
Unclear

Abstract

Melatonin, as the hormone of the circadian system, plays a major role in regulating physiological functions and facilitating adaptation to environmental changes. Here we provide brief overview of circadian physiology, as related to the use of melatonin as hormone replacement therapy for older individuals with reduced melatonin secretion and melatonin treatment for patients with chronic insomnia or circadian desynchronization. Emphasizing the importance of minimal effective doses, we discuss the use of both immediate and delayed-release formulations, stress the significance of regular administration timing, and advise against exposure to bright light during increase in melatonin levels. Our discussion underscores that the medical guidance is essential for utilizing melatonin-containing preparations in the therapy of chronic insomnia.

Zusammenfassung

An overview of circadian physiology, as related to the use of melatonin as hormone replacement therapy for older individuals with reduced melatonin secretion and melatonin treatment for patients with chronic insomnia or circadian desynchronization is provided.

Used In Evidence Reviews

Similar Papers